DHEA-S
DHEA-S Basic information
- Product Name:
- DHEA-S
- Synonyms:
-
- 10,13-dimethyl-17-oxo-3-sulfooxy-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene
- Formylisoglutamic acid
- Dehydroepiandrosterone Sulfate
- DEHYDROEPIANDROSTERONESULPHATE
- [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] hydrogen sulfate
- sulfuric acid [(3S,8R,9S,10R,13S,14S)-17-keto-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] ester
- (3β)-3-(Sulfooxy)androst-5-en-17-one
- Prasterone Sulfate Sports Nutrition Supplements Prasterone Sodium Sulfate 651-48-9
- CAS:
- 651-48-9
- MF:
- C19H28O5S
- MW:
- 368.49
- Mol File:
- 651-48-9.mol
DHEA-S Chemical Properties
- Boiling point:
- 468.81°C (rough estimate)
- Density
- 1.1763 (rough estimate)
- refractive index
- 1.5300 (estimate)
- Melting point:
- 190-192 °C
- pka
- -3.51±0.18(Predicted)
- form
- Solid
- color
- White to off-white
DHEA-S Usage And Synthesis
Uses
Dehydroepiandrosterone sulfate, a neuroactive neurosteroid, plays a major role in brain development and aging by influencing the migration of neurons, arborization of dendrites, and formation of new synapses[1][2][3].
Definition
ChEBI: A steroid sulfate that is the 3-sulfooxy derivative of dehydroepiandrosterone.
in vivo
DHEAS chronic administration produces a dose-dependent effect on performance[3].
| Animal Model: | Sixty-four male Sprague-Dawley rats, approximately 90 days of age (300-400 g)[3]. |
| Dosage: | 5, 10, or 20 mg/kg. |
| Administration: | Subcutaneous injection starting 7 days post-surgery and 1 h prior to all behavioral testing. |
| Result: | Significantly effective in improving latency to reach the platform as compared to injured rats receiving vehicle. |
IC 50
Human Endogenous Metabolite
References
[1] E E Baulieu, et al. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4089-91. DOI:10.1073/pnas.95.8.4089
[2] C R Parker Jr, et al. Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids. 1999 Sep;64(9):640-7. DOI:10.1016/s0039-128x(99)00046-x
[3] Stuart W Hoffman, et al. The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats. J Neurotrauma. 2003 Sep;20(9):859-70. DOI:10.1089/089771503322385791
DHEA-SSupplier
- Tel
- 028-81700200 18116577057
- 3003855609@qq.com
- Tel
- 0571-87396432
- sales@jhechem.com
- Tel
- 18620099427
- amy@howeipharm.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 0539-5636807 15318528770
- ffeng813@163.com
DHEA-S(651-48-9)Related Product Information
- Phosphoric acid
- Dehydroepiandrosterone
- Dehydroepiandrosterone
- ABiraterone impurity 15
- Abiraterone Acetate Dimer Impurity
- (3β)-Androsta-5,16-diene-3,17-diol 3-Acetate 17-(Trifluoromethanesulfonate)
- DIETHYL(3-PYRIDYL)BORANE
- Abiraterone Sulfate Sodium Salt
- Abiraterone Impurity 4
- Abiraterone Ethyl Ether
- Dehydroepiandrosterone acetate
- Abiraterone
- Abiraterone N-Oxide
- Abiraterone Related CoMpound 2 (Prasterone Triflate)
- Abiraterone Sulfate
- Abiraterone Related Compound 8
- Abiraterone DiMer IMpurity (Prasteronyl Abiraterone)
- 17-Iodoandrosta-5,16-dien-3beta-ol